As of Jul 20
| +0.52 / +4.60%|
The 4 analysts offering 12-month price forecasts for GlycoMimetics Inc have a median target of 14.50, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +22.57% increase from the last price of 11.83.
The current consensus among 5 polled investment analysts is to Buy stock in GlycoMimetics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.